Breaking the Generic Mold: How India’s ₹5,000-Crore Plan Could Redefine Pharma
The Government of India has extended the application deadline for its ambitious ₹5,000-crore Promotion of Research & Innovation in Pharma-MedTech (PRIP) scheme, offering more time…
November 9








